Myocarditis in auto-immune or auto-inflammatory diseases
نویسندگان
چکیده
منابع مشابه
Auto-inflammatory diseases
Auto-inflammatory diseases are a rapidly moving field, where the description of new entities, the understanding of the pathogenesis and the treatment has shown important progress in the past years. This group of conditions include monogenic auto-inflammatory diseases, like FMF, CAPS, TRAPS and MKD, and non-monogenic autoinflammatory diseases, like PFAPA, SoJIA, CRMO, and Behçet. The most common...
متن کاملAutophagy, NLRP3 inflammasome and auto-inflammatory/immune diseases.
Loss of homeostasis, as a result of pathogen invasion or self imbalance, causes tissue damage and inflammation. In addition to its well-established role in promoting clearance of pathogens or cell corpses, inflammation is also key to drive tissue repair and regeneration. Conserved from flies to humans, a transient, well-balanced inflammatory response is critical for restoration of tissue homeos...
متن کاملVitiligo and auto immune diseases: A survey of 100 patients
Vitiligo is an autoimmune skin disease which is characterized by depigmented patches due to loss of pigment cells. Evidence suggests that cell-mediated immunity plays a role in melanocyte destruction while some patients have antibodies to melanocytes or melanocytic proteins. Vitiligo is strongly associated with a number of autoimmune disorders. Autoimmune thyroiditis is the most prevalent disea...
متن کاملAuto-Hæmic or Auto-Serum Therapy
_ By D. N. SEN, l-m.s., Pathologist, Sambhunath Pandit Hospital, Alipore? Note by Major GOURLAY, d-s.o-, Surgeon Supdt., Sambhunath Pandit Hospital. In introducing this paper by Dr. D. N. Sen, Pathologist of the Sambhunath Pandit Hospital. I must admit that I have no first-hand acquaintance with the literature of auto-haemic therapy. At the same time, the subject appears to be an extraordinaril...
متن کاملSafety of rituximab in children with auto-immune diseases
Results We identified 169 children treated for refractory AID: autoimmune cytopenia (s) (104 patients), systemic lupus erythematosus (SLE) (52 patients), miscellaneous (13 patients). The mean follow-up period was 6 to 36 months. Patients received 2 to 4 rituximab infusions (350–750 mg/m2) associated with immunosuppressive drugs in 49/ 52 SLE patients. Replacement intravenous immunoglobulins the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Autoimmunity Reviews
سال: 2017
ISSN: 1568-9972
DOI: 10.1016/j.autrev.2017.05.021